Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Inventiva (IVA.US)$ Inventiva (NASDAQ:[Share Link: IVA]) re...

$Inventiva(IVA.US)$ Inventiva (NASDAQ:IVA) reported a Phase 2 study of its drug candidate lanifibranor met its primary efficacy endpoint in the treatment of patients with MASH/NASH and type 2 diabetes.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2841 Views
Comment
Sign in to post a comment
    2476Followers
    30Following
    33KVisitors
    Follow